Stock CLARI CLARIANE SE
Add to a list
To use this feature you must be a member
Log inSign up

Financials Clariane SE

Equities

CLARI

FR0010386334

Healthcare Facilities & Services

Market Closed - Euronext Paris
Other stock markets
 11:35:28 2024-07-05 am EDT 		5-day change 1st Jan Change
2.238 EUR +13.26% Intraday chart for Clariane SE +21.63% -6.91%
Jul. 03 CLARIANE : Balance sheet strengthening completed Alphavalue
Jul. 03 CLARIANE : Allowing for the completion of the recap with preferential subscription rights Alphavalue

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,467 3,291 2,938 1,068 256.7 318.6 - -
Enterprise Value (EV) 1 9,630 9,841 9,950 8,605 8,134 8,195 8,187 8,153
P/E ratio 32.5 x 104 x 38.1 x 77.8 x -2.43 x 17.2 x 9.73 x 8.95 x
Yield 1.43% 0.96% 1.08% 2.47% - 3.13% 4.92% 4.92%
Capitalization / Revenue 0.96 x 0.85 x 0.68 x 0.24 x 0.05 x 0.06 x 0.06 x 0.05 x
EV / Revenue 2.67 x 2.54 x 2.31 x 1.9 x 1.61 x 1.55 x 1.47 x 1.39 x
EV / EBITDA 10.9 x 11.4 x 9.85 x 8.58 x 7.96 x 7.81 x 7.32 x 6.81 x
EV / FCF 22,631 x 35.8 x 31.6 x 35.9 x 26.3 x 50.2 x 44.9 x 36.6 x
FCF Yield 0% 2.79% 3.17% 2.78% 3.8% 1.99% 2.23% 2.73%
Price to Book 1.35 x 0.91 x 0.84 x 0.3 x 0.07 x 0.21 x 0.14 x 0.14 x
Nbr of stocks (in thousands) 82,701 105,016 105,546 105,546 106,781 142,345 - -
Reference price 2 41.92 31.34 27.84 10.12 2.404 2.238 2.238 2.238
Announcement Date 2/27/20 2/24/21 2/23/22 2/21/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,612 3,874 4,311 4,534 5,048 5,295 5,578 5,886
EBITDA 1 884.9 861.1 1,010 1,003 1,021 1,050 1,118 1,197
EBIT 1 374.3 304.4 341.9 348.3 328.1 327.5 371.6 393.8
Operating Margin 10.36% 7.86% 7.93% 7.68% 6.5% 6.18% 6.66% 6.69%
Earnings before Tax (EBT) 1 175.5 60 131.9 57.9 -76.2 -37 56 51
Net income 1 114.7 39.4 94.6 22.1 -105.2 46.8 83.2 88.9
Net margin 3.18% 1.02% 2.19% 0.49% -2.08% 0.88% 1.49% 1.51%
EPS 2 1.290 0.3000 0.7300 0.1300 -0.9900 0.1300 0.2300 0.2500
Free Cash Flow 1 0.4255 274.8 315.2 239.5 309.1 163.3 182.3 222.8
FCF margin 0.01% 7.09% 7.31% 5.28% 6.12% 3.08% 3.27% 3.79%
FCF Conversion (EBITDA) 0.05% 31.92% 31.22% 23.87% 30.26% 15.55% 16.3% 18.61%
FCF Conversion (Net income) 0.37% 697.52% 333.24% 1,083.71% - 348.93% 219.11% 250.62%
Dividend per Share 2 0.6000 0.3000 0.3000 0.2500 - 0.0700 0.1100 0.1100
Announcement Date 2/27/20 2/24/21 2/23/22 2/21/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1
Net sales 1 1,845 1,876 2,108 1,082 1,121 - 1,094 1,130 2,224 1,135 1,190 - 1,267 2,485 1,246 1,316 - 1,308 1,313 2,621
EBITDA - 407.3 - - - - - - 491.1 - - - - 482 - - - - - -
EBIT 211.6 141 166.2 - - 175.7 - - 168.9 - - 179.4 - 144.5 - - 183.6 - - 275
Operating Margin 11.47% 7.51% 7.89% - - - - - 7.59% - - - - 5.82% - - - - - 10.49%
Earnings before Tax (EBT) - - - - - - - - - - - - - - - - - - - -
Net income 54.6 - - - - - - - - - - - - - - - - - - -
Net margin 2.96% - - - - - - - - - - - - - - - - - - -
EPS - - - - - - - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - -
Announcement Date 2/27/20 7/30/20 7/29/21 10/28/21 2/23/22 2/23/22 4/25/22 7/28/22 7/28/22 10/27/22 2/21/23 2/21/23 7/27/23 7/27/23 10/24/23 2/28/24 2/28/24 4/25/24 - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 6,163 6,550 7,012 7,537 7,877 7,877 7,869 7,834
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 6.965 x 7.607 x 6.944 x 7.513 x 7.714 x 7.502 x 7.036 x 6.543 x
Free Cash Flow 1 0.43 275 315 240 309 163 182 223
ROE (net income / shareholders' equity) 4.48% 1.38% 2.84% 0.63% -2.95% 1.5% 2.3% 2.4%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 31.10 34.30 33.20 33.80 33.70 10.90 15.70 15.70
Cash Flow per Share 2 8.280 7.510 6.990 7.150 7.460 1.560 1.880 1.710
Capex 1 311 520 539 622 484 633 495 517
Capex / Sales 8.6% 13.43% 12.49% 13.72% 9.59% 11.95% 8.88% 8.78%
Announcement Date 2/27/20 2/24/21 2/23/22 2/21/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Clariane SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.238 EUR
Average target price
2.2 EUR
Spread / Average Target
-1.70%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CLARIANE SE Stock Clariane SE
-6.91% 345M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.33% 83.89B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-28.29% 71.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+0.99% 26.77B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+3.67% 17.74B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-9.99% 17.24B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+1.86% 15.6B
NATERA, INC. Stock Natera, Inc.
+79.98% 13.84B
PURE HEALTH HOLDING Stock Pure Health Holding
-25.09% 12.92B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+74.41% 12.87B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CLARI Stock
  4. Financials Clariane SE